Status:

COMPLETED

A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)

Lead Sponsor:

CSL Behring

Conditions:

Multifocal Motor Neuropathy (MMN)

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The objective of this study is to assess efficacy, safety, and convenience of purified human antibodies administered under the skin in the treatment of MMN patients.

Eligibility Criteria

Inclusion

  • Patients with documented clinical diagnosis and electrophysiological evidence of MMN
  • Patients who have previously responded to intravenous immunoglobulin (IVIG) and have been on stable treatment with IVIG for at least 12 weeks prior to screening
  • Patients treated with the equivalent of ≥0.4g/kg body weight (bw) IVIG per month
  • Provision of informed consent by patient

Exclusion

  • Aspartate aminotransferase (ASAT) or alanine aminotransferase (ALAT) concentration \>2.5 times the upper normal limit (UNL)
  • Creatinine concentration \>1.5 times the UNL
  • Known allergic reactions to blood products
  • Any skin disease interfering with the assessment of injection site reactions
  • Any other medical condition, which in the opinion of the investigator, might interfere with successful completion of the protocol
  • Any condition likely to interfere with the evaluation of the study drug or satisfactory conduct of the trial
  • Participation in a study with an investigational drug within three months prior to enrolment
  • Patients treated with the equivalent of \>2.0g/kg bw IVIG per month

Key Trial Info

Start Date :

November 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT00701662

Start Date

November 1 2007

End Date

January 1 2009

Last Update

August 1 2013

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

San Raffaele Hospital

Milan, Italy

2

Inselspital

Bern, Switzerland

3

Dept. Clinical Immunology, Oxford Radcliffe Hospitals

Oxford, United Kingdom